Health Care: Drugs

NewLink Genetics Corp (NLNK: NASDAQ)

$7.26 n/a | n/a%
07/21/17 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 7.26
52 Week High 25.17
52 Week Low 5.90
Avg. Daily Vol. (Mil) 0.86
Beta (3 year) 2.32
Share Related Items
Mkt Cap (Mil) 212.18
Shares Out (Mil) 29.23
Float (Mil) 21.66
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 4.10
Current Ratio 4.40
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 5.93
Price/Book 1.53
Price/Cash Flow -2.40
Per Share Data
Earnings -2.94
Sales 1.22
Book Value 4.73
Cash Flow -2.98
Business Summary
NewLink Genetics Corp is a clinical stage immuno-oncology company based in US. It focuses on developing novel immunotherapeutic products for the treatment of cancer. Its portfolio contains biologic and small-molecule immuno-oncology product candidates.
General Information
2503 South Loop Drive
Suite 5100
Ames, IA 50010
Industry : Drugs
Sector: Health Care
Employees: 210
CEO: Mr. Charles J. Link, Jr
Short Interest
Current Month (Mil) 4.85
Previous Month (Mil) 4.86
Short Interest Ratio (Days) 3.60
Management Effectiveness
Return on Equity n.a.
Return on Assets -50.00
Return on Investments -67.30
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with NLNK

Latest NLNK Headlines from TheStreet

More Financial News for NLNK

Press Releases for NLNK

See All Press Releases

Partner Headlines for NLNK

brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter